Financhill
Back

Genpact Vs. Intra-Cellular Therapies Industry Stock Comparison

Buy
60

G
Genpact

Last Price:
$44.21
Seasonality Move:
2.42%
Buy
61

ITCI
Intra-Cellular Therapies

Last Price:
$126.86
Seasonality Move:
2.9%
Buy
60
Genpact (G) is a Buy

Is Genpact a Buy, Sell or Hold?

  • The current Genpact [G] share price is $44.20. The Score for G is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
  • G is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
61
Intra-Cellular Therapies (ITCI) is a Buy

Is Intra-Cellular Therapies a Buy, Sell or Hold?

  • The current Intra-Cellular Therapies [ITCI] share price is $126.89. The Score for ITCI is 61, which is 22% above its historic median score of 50, and infers lower risk than normal.
  • ITCI is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

G Stock Price Chart

What is Genpact's stock price today?

  • The Genpact share price today is $44.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and G is experiencing selling pressure, which indicates risk of future bearish movement.

ITCI Stock Price Chart

What is Intra-Cellular Therapies's stock price today?

  • The Intra-Cellular Therapies share price today is $126.89
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ITCI is experiencing selling pressure, which indicates risk of future bearish movement.

G Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.01 Sell
Relative Strength Index (14 RSI): 56.09 Buy
Chaikin Money Flow: -981301 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.61 - 44.45) Buy
Bollinger Bands (100): (38.43 - 44.33) Buy

ITCI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 6.34 Buy
Relative Strength Index (14 RSI): 87.18 Buy
Chaikin Money Flow: -9953478 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (76.29 - 99.79) Buy
Bollinger Bands (100): (72.19 - 89.87) Buy

G Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 43.55 Buy
20-day SMA: 43.19 Buy
50-day SMA: 43.89 Buy
200-day SMA: 37.11 Buy
8-day EMA: 43.64 Buy
20-day EMA: 43.56 Buy
50-day EMA: 43.05 Buy
200-day EMA: 39.16 Buy

ITCI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 95.56 Buy
20-day SMA: 89.05 Buy
50-day SMA: 87.32 Buy
200-day SMA: 76.32 Buy
8-day EMA: 102.15 Buy
20-day EMA: 92.65 Buy
50-day EMA: 87.08 Buy
200-day EMA: 77.64 Buy

Genpact Earnings Growth & G Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.22 per share, and an increase next year of $0.32 per share.

Intra-Cellular Therapies Earnings Growth & ITCI Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.89 per share, and an increase next year of $3.13 per share.

Genpact Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Intra-Cellular Therapies Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):